310 related articles for article (PubMed ID: 33137488)
1. The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice.
Rajas F; Dentin R; Cannella Miliano A; Silva M; Raffin M; Levavasseur F; Gautier-Stein A; Postic C; Mithieux G
Mol Metab; 2021 Jan; 43():101108. PubMed ID: 33137488
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
3. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.
Monteillet L; Gjorgjieva M; Silva M; Verzieux V; Imikirene L; Duchampt A; Guillou H; Mithieux G; Rajas F
Mol Metab; 2018 Oct; 16():100-115. PubMed ID: 30100243
[TBL] [Abstract][Full Text] [Related]
4. The Mediator complex kinase module is necessary for fructose regulation of liver glycogen levels through induction of glucose-6-phosphatase catalytic subunit (G6pc).
Youn DY; Xiaoli AM; Zong H; Okada J; Liu L; Pessin J; Pessin JE; Yang F
Mol Metab; 2021 Jun; 48():101227. PubMed ID: 33812059
[TBL] [Abstract][Full Text] [Related]
5. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
[TBL] [Abstract][Full Text] [Related]
6. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C
J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368
[TBL] [Abstract][Full Text] [Related]
7. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
[TBL] [Abstract][Full Text] [Related]
8. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes.
Arden C; Tudhope SJ; Petrie JL; Al-Oanzi ZH; Cullen KS; Lange AJ; Towle HC; Agius L
Biochem J; 2012 Apr; 443(1):111-23. PubMed ID: 22214556
[TBL] [Abstract][Full Text] [Related]
9. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
[TBL] [Abstract][Full Text] [Related]
10. F6P/G6P-mediated ChREBP activation promotes the insulin resistance-driven hepatic lipid deposition in zebrafish.
Gong Y; Lu Q; Xi L; Liu Y; Yang B; Su J; Liu H; Jin J; Zhang Z; Yang Y; Zhu X; Xie S; Han D
J Nutr Biochem; 2023 Dec; 122():109452. PubMed ID: 37748621
[TBL] [Abstract][Full Text] [Related]
11. Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
Farah BL; Landau DJ; Sinha RA; Brooks ED; Wu Y; Fung SYS; Tanaka T; Hirayama M; Bay BH; Koeberl DD; Yen PM
J Hepatol; 2016 Feb; 64(2):370-379. PubMed ID: 26462884
[TBL] [Abstract][Full Text] [Related]
12. Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase.
Shi JH; Lu JY; Chen HY; Wei CC; Xu X; Li H; Bai Q; Xia FZ; Lam SM; Zhang H; Shi YN; Cao D; Chen L; Shui G; Yang X; Lu Y; Chen YX; Zhang WJ
Diabetes; 2020 Apr; 69(4):591-602. PubMed ID: 31974143
[TBL] [Abstract][Full Text] [Related]
13. Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib.
Krishnamurthy KA; Rutten MGS; Hoogerland JA; van Dijk TH; Bos T; Koehorst M; de Vries MP; Kloosterhuis NJ; Havinga H; Schomakers BV; van Weeghel M; Wolters JC; Bakker BM; Oosterveer MH
Mol Metab; 2024 Jan; 79():101838. PubMed ID: 37995884
[TBL] [Abstract][Full Text] [Related]
14. Glucose-6-Phosphate Regulates Hepatic Bile Acid Synthesis in Mice.
Hoogerland JA; Lei Y; Wolters JC; de Boer JF; Bos T; Bleeker A; Mulder NL; van Dijk TH; Kuivenhoven JA; Rajas F; Mithieux G; Haeusler RA; Verkade HJ; Bloks VW; Kuipers F; Oosterveer MH
Hepatology; 2019 Dec; 70(6):2171-2184. PubMed ID: 31102537
[TBL] [Abstract][Full Text] [Related]
15. Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein.
Agius L
Proc Nutr Soc; 2016 Feb; 75(1):10-18. PubMed ID: 26264689
[TBL] [Abstract][Full Text] [Related]
16. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver.
Dentin R; Tomas-Cobos L; Foufelle F; Leopold J; Girard J; Postic C; Ferré P
J Hepatol; 2012 Jan; 56(1):199-209. PubMed ID: 21835137
[TBL] [Abstract][Full Text] [Related]
17. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes.
Al-Oanzi ZH; Fountana S; Moonira T; Tudhope SJ; Petrie JL; Alshawi A; Patman G; Arden C; Reeves HL; Agius L
Diabetes Obes Metab; 2017 Aug; 19(8):1078-1087. PubMed ID: 28206714
[TBL] [Abstract][Full Text] [Related]
19. The Protective Role of the Carbohydrate Response Element Binding Protein in the Liver: The Metabolite Perspective.
Agius L; Chachra SS; Ford BE
Front Endocrinol (Lausanne); 2020; 11():594041. PubMed ID: 33281747
[TBL] [Abstract][Full Text] [Related]
20. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity.
Zhang S; Guo F; Yu M; Yang X; Yao Z; Li Q; Wei Z; Feng K; Zeng P; Zhao D; Li X; Zhu Y; Miao QR; Iwakiri Y; Chen Y; Han J; Duan Y
J Hepatol; 2020 Dec; 73(6):1482-1495. PubMed ID: 32738448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
